A world-first treatment, developed in Perth, is showing promising results in protecting the brain after concussion.
The neuro-protective drug could limit the damage from a head knock, sparing patients from the life-changing effects of traumatic injury.
ARG-007 is a medication seeking approval to help save lives.
“[It’s a] One shot wonder type of drug,” Dr Liz Dallimore told 9News.
The neuro-protective peptide, which is administered intravenously, is offering hope to those who suffer a concussion or other traumatic brain injuries.
It impacts an estimated 69 million people worldwide and is one of the leading causes of death and disability.
The most recent pre-clinical trial conducted by the University of Adelaide has demonstrated successful outcomes after evaluations on ferrets.
It was found to reduce brain damage and improving motor and memory function.
“Because it’s a really small peptide it can sneak into the brain and that means it can act on the neurons within the brain and protect them from the damage following a head injury,” Francis Corrigan, Associate Professor at the University of Adelaide told 9News.
Human trials for traumatic brain injury are set start next year, with ARG-007 to be rolled out at hospitals in Perth and nationally.
Results for a recent roll out on stroke patients in emergency departments across the country are expected next month.
“Our aspiration for this drug is to see it included in every ambulance globally,” Dallimore stated.
